Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial

Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial

Abstract Background Stereotactic body radiotherapy (SBRT) is becoming increasingly used in treating localized prostate cancer (PCa), with evidence showing similar toxicity and efficacy profiles when compared with longer courses of definitive radiation. Magnetic resonance imaging (MRI)-guided radioth...

Full description

Bibliographic Details
Main Authors: Ting Martin Ma, James M. Lamb, Maria Casado, Xiaoyan Wang, T. Vincent Basehart, Yingli Yang, Daniel Low, Ke Sheng, Nzhde Agazaryan, Nicholas G. Nickols, Minsong Cao, Michael L. Steinberg, Amar U. Kishan
Format: Article
Language:English
Published: BMC 2021-05-01
Series:BMC Cancer
Subjects:
Prostate Cancer
Stereotactic body radiotherapy (SBRT)
Magnetic resonance imaging (MRI)
Computed tomography (CT)
Genitourinary (GU) toxicity
Gastrointestinal (GI) toxicity
Online Access:https://doi.org/10.1186/s12885-021-08281-x

Internet

https://doi.org/10.1186/s12885-021-08281-x

Similar Items